electroCore Provides Update on 510(k) Submission Seeking Expanded Indication for gammaCore™

    NEXT STORY
    HOOKIPA Announces Key Hires to its Executive Team
    PREV STORY
    Dance Biopharm Announces Rebranding to Aerami Therapeutics Reflecting a Broadened Strategic Focus on Inhaled Therapies for Chronic Diseases
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dova Pharmaceuticals Reports First Quarter 2019 Operating and Financial Results

    author_avatar
    NASDAQ Market News

    Cesca Therapeutics to Present at the Inaugural Cell and Gene Exchange 2017

    RANCHO CORDOVA, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

    author_avatar
    NASDAQ Market News

    Nova Southeastern University Receives $8.5 Million Grant from Department of Defense for Second Phase of Gulf War Illness Research

    Fort Lauderdale/Davie, Nov. 15, 2018 (GLOBE NEWSWIRE) -- The U.S. Department of Defense (DoD) ...

    author_avatar
    NASDAQ Market News